Skip to main content

Table 1 Clinical Characteristics of study subjects for this study

From: Comprehensive analysis of T-cell receptor repertoire in patients with acute coronary syndrome by high-throughput sequencing

Variables

NCA (n = 9)

UA (n = 9)

AMI (n = 14)

P valuea

Age, years

55.4 ± 6.95

56.1 ± 5.46

59.86 ± 6.76

0.28

Gender (F/M)

5/4

5/4

8/6

0.99

Current smoking, n (%)

2(22.2%)

2(22.2%)

4(28.6%)

0.91

Triglycerides, mmol/L

1.36 ± 0.56

1.71 ± 0.56

1.98 ± 1.19

0.49

Cholesterol, mmol/L

4.85 ± 1.00

5.26 ± 1.23

4.69 ± 1.48

0.58

HDL, mmol/L

1.25 ± 0.27

1.25 ± 0.24

1.11 ± 0.24

0.30

LDL, mmol/L

2.66 ± 0.62

3.01 ± 0.76

2.64 ± 0.80

0.47

Medicine use

 Nitrate esters drug, n (%)

0

1(11.1%)

0

0.26

 Clopidogrel, n (%)

1(11.1%)

5(55.6%)

5(35.7%)

0.08

 Statins, n (%)

0

6(66.7%)

1(7.1%)

< 0.01

 Aspirin, n (%)

2(22.2%)

7(77.8%)

6(42.9%)

0.06

 ACEI/ARB, n (%)

0

4(44.4%)

1(7.1%)

0.01

 Ca2+ antagonist, n (%)

0

2(22.2%)

0

0.06

 β - blocker, n (%)

1(11.1%)

6(66.7%)

0

< 0.01

  1. HDL High-density lipoprotein;
  2. LDL Low-density lipoprotein;
  3. ACEI/ARB Angiotensin-converting enzyme inhibitors/angiotensin antibody;
  4. acomparison between three groups using one-way ANOVA or Chi-square